Do Options Traders Know Something About Insulet Stock We Don't?
Here's Why Insulet (PODD) is a Strong Momentum Stock
Insulet (PODD) Just Overtook the 50-Day Moving Average
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting Transcript
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
Insulet Corporation Valuation Pressure Has Dropped Enough (Upgrade)
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
PODD Stock: What a Hold Rating Says at a $163 Target
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
Stock Futures Higher as Micron Stock Extends Rally
Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
Insulet Corp (PODD) Shares Surge 3.5% -- What GF Score of 82 Tells Investors
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Insulet: An Opportune Time To Get Involved
Here's Why Insulet (PODD) is a Strong Growth Stock
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More
Why Insulet (PODD) is a Top Value Stock for the Long-Term
Insulet Corporation (PODD) Q1 2026 Earnings Call Transcript
Insulet (PODD) Loses 17.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand
Insulet Reports First Quarter 2026 Results
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
Insulet (PODD) is an Incredible Growth Stock: 3 Reasons Why
Insulet (PODD) Upgraded to Buy: Here's Why
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
Insulet Corp (PODD) Shares Surge 7.6% -- What GF Score of 85 Tells Investors
PAHC vs. PODD: Which Stock Is the Better Value Option?
FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns
Insulet to Participate in BofA Securities 2026 Health Care Conference
Analyzing Insulet (NASDAQ:PODD) and NWT Uranium (OTCMKTS:CPTRF)
Insulet Corporation $PODD Stock Position Reduced by AEGON ASSET MANAGEMENT UK Plc
Here Are Friday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Comcast, Draft Kings, IBM, Oracle, Shake Shack, Southwest Airlines, Tesla, and More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Parnassus Growth Equity Fund Q1 2026 Portfolio Activity
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD